Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 7:11:571476.
doi: 10.3389/fonc.2021.571476. eCollection 2021.

Beta-Elemene Reduces the Malignancy of Non-Small Cell Lung Cancer by Enhancing C3orf21 Expression

Affiliations

Beta-Elemene Reduces the Malignancy of Non-Small Cell Lung Cancer by Enhancing C3orf21 Expression

Hu Cai et al. Front Oncol. .

Abstract

Background: Beta-elemene has potent anti-tumor effect, but its anti-tumor mechanism remains unclear. Chromosome 3 open reading frame 21 (C3orf21) acts as a tumor suppressor. This study tested whether the anti-tumor effect of beta-elemene was associated with modulating C3orf21 expression in non-small cell lung cancer (NSCLC).

Materials and methods: The impact of beta-elemene on C3orf21 expression in NSCLC cells was quantified. The stable C3orf21 silencing A549 and over-expressing PC-9 cells were established and their effects on the beta-elemene-attenuated proliferation, wound healing and invasion of NSCLC cells as well as the expression of key regulators and signal events were determined.

Results: Beta-elemene significantly up-regulated C3orf21 expression in NSCLC cells. Beta-elemene treatment significantly attenuated the proliferation, wound healing and invasion of NSCLC cells, which were significantly mitigated by C3orf21 silencing, but enhanced by C3orf21 over-expression. Similar patterns of beta-elemene-modulated cyclinD1, c-Myc, COX2, MMP2, MMP9, VEGF, PTEN and Notch1 expression were detected in NSCLC cells.

Conclusions: Such data indicated that beta-elemene treatment attenuated the malignancy of NSCLC cells by up-regulating C3orf21 expression. Our findings may provide new mechanisms underlying the pharmacological action of beta-elemene.

Keywords: C3orf21; elemene injection; malignancy; mechanisms; non-small cell lung cancer.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
The structure of beta-elemene.
Figure 2
Figure 2
The network of beta-elemene with the potential targeted genes. green rhombus represents beta-elemene; blue ellipse represent the targeted genes of beta-elemene; red ellipse represent the XXYLT1.
Figure 3
Figure 3
A network of beta-elemene with the potential interacted proteins. Gray lines indicate protein-protein interactions; Green lines indicate compound–protein interactions.
Figure 4
Figure 4
C3orf21 expression in NSCLC cells. (A) Western blot analysis of the relative levels of C3orf21 expression in the indicated NSCLC cells. (B) Beta-elemene enhances C3orf21 expression in NSCLC cells. (C, D) Generation of C3orf21 stable silencing A549 cells and C3orf21 stable over-expressing PC-9 cells. Data are representative images or expressed as the mean ± SD of each group from three biological experiments. *P < 0.05, **P < 0.01 and ***P < 0.001 vs. the control.
Figure 5
Figure 5
Beta-elemene inhibits the proliferation of NSCLC cells. A549, PC-9, A549-shNC and A549-shC3orf21 cells were treated with, or without, the indicated concentrations of beta-elemene for 24 h and the cell proliferation was determined by CCK-8 assays. Data are expressed as the mean ± SD of each dose group from three biological experiments. (A, B) The proliferation of A549 cells. (B) The proliferation of PC-9 cells. (C) The proliferation of A549-shNC and A549-shC3orf21 cells. (D) The proliferation of PC-9-NC and PC-9-C3orf21 over-expression. *P < 0.05, **P < 0.01 and ***P < 0.001 vs. the control.
Figure 6
Figure 6
Beta-elemene attenuates the wound healing and invasion of NSCLC cells. (A) The wound healing of A549 cells. (B) The wound healing of PC-9 cells. (C) The invasion of A549 cells. (D) The invasion of PC-9 cells. Data are representative images or expressed as the mean ± SD of each group from three biological experiments. **P < 0.01 and ***P < 0.001 vs. the control.
Figure 7
Figure 7
Beta-elemene modulates the expression of several regulators and signal events in NSCLC cells, dependent on C3orf21 expression. The indicated NSCLC cells were treated with, or without, beta-elemene for 24 h and the relative levels of MMP-2 (A), MMP-9 (B), VEGF (C), PTEN (D) Cyclin (E), C-Myc (F), and COX2 (G) in the indicated NSCLC cells were quantified by RT-PCR. Data are present as mean ± SD of each group from at least three biological experiments. **P < 0.01 and ***P < 0.001 vs. the control.
Figure 8
Figure 8
Beta-elemene decreases C3orf21 protein expression in NSCLC cells. The indicated NSCLC cells were treated with, or without, beta-elemene for 24 and their relative levels of Notch1 protein expression (A, B) were quantified by Western blot. Data are representative images or present as mean ± SD of each group from at least three biological experiments. **P < 0.01 and ***P < 0.001 vs. the control.

References

    1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer Incidence and Mortality Worldwide: Sources, Methods and Major Patterns in GLOBOCAN 2012. Int J Cancer (2015) 136:E359–86. 10.1002/ijc.29210 - DOI - PubMed
    1. Sullivan I, Planchard D. ALK Inhibitors in non-Small Cell Lung Cancer: The Latest Evidence and Developments. Ther Adv Med Oncol (2016) 8:32–47. 10.1177/1758834015617355 - DOI - PMC - PubMed
    1. Hsu YL, Kuo PL, Lin CC. Proliferative Inhibition, Cell-Cycle Dysregulation, and Induction of Apoptosis by Ursolic Acid in Human non-Small Cell Lung Cancer A549 Cells. Life Sci (2004) 75:2303–16. 10.1016/j.lfs.2004.04.027 - DOI - PubMed
    1. Luque M, Díez FJ, Disdier C. Optimal Sequence of Tests for the Mediastinal Staging of non-Small Cell Lung Cancer. BMC Med Inform Decis Mak (2016) 16:9. 10.1186/s12911-016-0246-y - DOI - PMC - PubMed
    1. Zhao S, Wu J, Zheng F, Tang Q, Yang L, Li L, et al. Beta- Beta-Elemene Inhibited Expression of DNA Methyltransferase 1 Through Activation of ERK1/2 and AMPKalpha Signalling Pathways in Human Lung Cancer Cells: The Role of Sp1. J Cell Mol Med (2015) 19:630–41. 10.1111/jcmm.12476 - DOI - PMC - PubMed